Their involvement in PARP/PARG/mADPr metabolism makes them proteins of current therapeutic interest in metabolic diseases such as cancer or neurodegenerative diseases, thanks to their involvement in mitochondrial stability and function. The gene discussed is PARP1; the disease is cancer.